Cargando…

Estimates of Presumed Population Immunity to SARS-CoV-2 by State in the United States, August 2021

BACKGROUND: Information is needed to monitor progress toward a level of population immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sufficient to disrupt viral transmission. We estimated the percentage of the US population with presumed immunity to SARS-CoV-2 due to vaccinati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stoner, Marie C D, Angulo, Frederick J, Rhea, Sarah, Brown, Linda Morris, Atwell, Jessica E, Nguyen, Jennifer L, McLaughlin, John M, Swerdlow, David L, MacDonald, Pia D M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774091/ https://www.ncbi.nlm.nih.gov/pubmed/35071687 http://dx.doi.org/10.1093/ofid/ofab647

Ejemplares similares

Population Attributable Fractions of Underlying Medical Conditions for Coronavirus Disease 2019 (COVID-19) Diagnosis and COVID-19 Hospitalizations, Ventilations, and Deaths Among Adults in the United States
por: Nguyen, Jennifer L, et al.
Publicado: (2022)

Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysis
por: McLaughlin, John M, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Reported Coronavirus Disease 2019 Cases in US Children, August 2020–May 2021
por: Couture, Alexia, et al.
Publicado: (2022)

Epidemiology and control of trachoma in the state of Ceará, Northeast Brazil, 2007-2021
por: Maciel, Adjoane Maurício Silva, et al.
Publicado: (2023)

Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016
por: Paik, James M, et al.
Publicado: (2020)

Testing for Cryptococcosis at a Major Commercial Laboratory—United States, 2019–2021
por: Benedict, Kaitlin, et al.
Publicado: (2022)

Impact of Age and Symptom Development on SARS-CoV-2 Transmission in Households With Children—Maryland, New York, and Utah, August 2020–October 2021
por: Sumner, Kelsey M, et al.
Publicado: (2022)

COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)
por: Hatcher, Sarah M., et al.
Publicado: (2022)

County-level Predictors of Coronavirus Disease 2019 (COVID-19) Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?
por: McLaughlin, John M, et al.
Publicado: (2020)

Surge in Incidence and Coronavirus Disease 2019 Hospital Risk of Death, United States, September 2020 to March 2021
por: Patel, Bela, et al.
Publicado: (2022)

Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020
por: Nguyen, Jennifer L., et al.
Publicado: (2022)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Behavioral and Social Drivers of COVID-19 Vaccination in the United States, August–November 2021
por: Bonner, Kimberly E., et al.
Publicado: (2023)

Trends in COVID-19 vaccination receipt and intention to vaccinate, United States, April to August, 2021
por: Nguyen, Kimberly H., et al.
Publicado: (2022)

Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020
por: Chamberlain, Allison T, et al.
Publicado: (2021)

The Epidemiology and Clinical Features of Non-Keratitis Acanthamoeba Infections in the United States, 1956–2020
por: Haston, Julia C, et al.
Publicado: (2023)

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
por: Lewis, Nathaniel M, et al.
Publicado: (2022)

Burden of Adults Hospitalized With Group B Streptococcal Infection
por: McLaughlin, John M, et al.
Publicado: (2020)

Population Immunity to Pre-Omicron and Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Variants in US States and Counties Through 1 December 2021
por: Klaassen, Fayette, et al.
Publicado: (2022)

Changing Epidemiology of Carbapenemases Among Carbapenem-Resistant Enterobacterales From United States Hospitals and the Activity of Aztreonam-Avibactam Against Contemporary Enterobacterales (2019–2021)
por: Sader, Helio S, et al.
Publicado: (2023)

In the literature: August 2021
por: Gambardella, V., et al.
Publicado: (2021)

Respiratory Syncytial Virus–Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis
por: McLaughlin, John M, et al.
Publicado: (2020)

Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States
por: Harcourt, Brian H., et al.
Publicado: (2015)

Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States
por: Tamma, Pranita D, et al.
Publicado: (2019)

County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis
por: McLaughlin, John M., et al.
Publicado: (2022)

Physician engagement in regularly scheduled rounds
por: Bass, Adam, et al.
Publicado: (2021)

Infectious Period of Severe Acute Respiratory Syndrome Coronavirus 2 in 17 Nursing Home Residents—Arkansas, June–August 2020
por: Surie, Diya, et al.
Publicado: (2021)

Heterogeneity Between States in the Health and Economic Impact of Measles Immunization in the United States
por: Paternina-Caicedo, Angel, et al.
Publicado: (2018)

Procalcitonin Monitoring and Antibiotic Duration in Presumed Lower Respiratory Tract Infections: A Propensity Score–Matched Cohort Across the Veterans Health Administration
por: Heren, Jamie E, et al.
Publicado: (2023)

Social Determinants of Health and Care Outcomes Among People With HIV in the United States
por: Menza, Timothy W, et al.
Publicado: (2021)

Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021
por: Siegel, David A., et al.
Publicado: (2021)

Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022
por: Klaassen, Fayette, et al.
Publicado: (2023)

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes
por: Hunter, Jennifer C., et al.
Publicado: (2016)

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
por: Lessa, Fernanda C., et al.
Publicado: (2014)

Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 — United States, March 2020–August 2021
por: Wiltz, Jennifer L., et al.
Publicado: (2022)

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals
por: Goodman, Katherine E, et al.
Publicado: (2022)

Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010
por: Rosenberg, Eli S., et al.
Publicado: (2017)

Microbial Musings – August 2021
por: Thomas, Gavin H.
Publicado: (2021)

INTERNATIONAL NEWS - August 2021
Publicado: (2021)

High Mortality Among Human Immunodeficiency Virus (HIV)-Infected Individuals Before Accessing or Linking to HIV Care: A Missing Outcome in the Cascade of Care?
por: Krentz, Hartmut B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nr8sbira851esmkmn58ccfn98n